Media & Events
Shardul Amarchand Mangaldas advises Krishna Institute of Medical Sciences Limited (KIMS) on its ₹1,500 crore qualified institutions placement
June 23, 2026
Shardul Amarchand Mangaldas & Co. (SAM) advised Krishna Institute of Medical Sciences Limited (KIMS), one of the key healthcare corporate groups in India, on its Qualified Institutions Placement (QIP) aggregating to ₹1,500 crore (approx. USD 158 million).
The QIP comprised participation from a diverse set of institutional investors, including the International Finance Corporation (IFC), as well as leading mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance and Kotak Mahindra Life Insurance.
The proceeds of the QIP are proposed to be utilised towards repayment and/or prepayment of certain outstanding borrowings availed by the Company and certain of its subsidiaries.
The transaction team comprised of Prashant Gupta, Partner and National Practice Head – Capital Markets, Ruth Chenchiah, Partner, Ritika Khare, Principal Associate; Anoushka PV, Senior Associate; Anaya Jain, Associate; and Kunika Agarwal, Associate.